Arax Advisory Partners’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.51K | Buy |
632
+173
| +38% | +$1.51K | ﹤0.01% | 2214 |
|
|
2025
Q1 | $3.65K | Buy |
459
+62
| +16% | +$494 | ﹤0.01% | 1886 |
|
|
2024
Q4 | $3.61K | Buy |
397
+376
| +1,790% | +$3.42K | ﹤0.01% | 1854 |
|
|
2024
Q3 | $193 | Hold |
21
| – | – | ﹤0.01% | 2515 |
|
|
2024
Q2 | $206 | Sell |
21
-342
| -94% | -$3.36K | ﹤0.01% | 2435 |
|
|
2024
Q1 | $5.48K | Sell |
363
-16
| -4% | -$242 | ﹤0.01% | 883 |
|
|
2023
Q4 | $8.17K | Sell |
379
-106
| -22% | -$2.28K | ﹤0.01% | 793 |
|
|
2023
Q3 | $9.02K | Sell |
485
-21
| -4% | -$390 | ﹤0.01% | 744 |
|
|
2023
Q2 | $12.8K | Sell |
506
-42
| -8% | -$1.06K | ﹤0.01% | 664 |
|
|
2023
Q1 | $14.2K | Hold |
548
| – | – | ﹤0.01% | 634 |
|
|
2022
Q4 | $13K | Sell |
548
-2
| -0.4% | -$47 | ﹤0.01% | 615 |
|
|
2022
Q3 | $14K | Hold |
550
| – | – | ﹤0.01% | 618 |
|
|
2022
Q2 | $18K | Hold |
550
| – | – | ﹤0.01% | 575 |
|
|
2022
Q1 | $40K | Hold |
550
| – | – | 0.01% | 483 |
|
|
2021
Q4 | $51K | Hold |
550
| – | – | 0.01% | 455 |
|
|
2021
Q3 | $70K | Buy |
550
+15
| +3% | +$1.91K | 0.01% | 404 |
|
|
2021
Q2 | $89K | Buy |
+535
| New | +$89K | 0.01% | 359 |
|
|
2020
Q4 | $149K | Buy |
745
+222
| +42% | +$44.4K | 0.02% | 239 |
|
|
2020
Q3 | $115K | Buy |
523
+246
| +89% | +$54.1K | 0.02% | 251 |
|
|
2020
Q2 | $53K | Hold |
277
| – | – | 0.01% | 358 |
|
|
2020
Q1 | $43K | Hold |
277
| – | – | 0.01% | 372 |
|
|
2019
Q4 | $23K | Hold |
277
| – | – | 0.01% | 407 |
|
|
2019
Q3 | $19K | Hold |
277
| – | – | 0.01% | 415 |
|
|
2019
Q2 | $18K | Buy |
+277
| New | +$18K | 0.01% | 420 |
|
|
2018
Q4 | $14K | Hold |
277
| – | – | 0.01% | 412 |
|
|
2018
Q3 | $24K | Buy |
+277
| New | +$24K | 0.01% | 384 |
|